Mask use by patients in the context of COVID-19 can increase the risk of postinjection endophthalmitis

Acta Ophthalmol. 2022 May;100(3):e859-e860. doi: 10.1111/aos.14945. Epub 2021 Jun 21.

Authors

Kathrine Blom^{1

2}, Ragnheiður Bragadóttir^{1

2}, Magne Sand Sivertsen¹, Morten Carstens Moe^{1

2}, Øystein Kalsnes Jørstad^{1

2}

Affiliations

¹ Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
² Faculty of Medicine, University of Oslo, Oslo, Norway.

No abstract available

Publication types

Letter

MeSH terms

COVID-19* / epidemiology
Endophthalmitis* / drug therapy
Endophthalmitis* / epidemiology
Endophthalmitis* / etiology
Eye Infections, Bacterial* / drug therapy
Humans
Intravitreal Injections

Grants and funding

Norges Blindeforbund